Salehi M, Aulinger BA, DAlessio DA
Seo Y, Lim H, Park H, Yu J, An J, Yoo HY et al (2023) Recent progress of lipid nanoparticles-based lipophilic drug delivery: focus on surface modifications
GLP-1 receptor agonists significantly lowered CRP levels (standardised mean difference of 0.39) and TNF- levels (SMD of 0.51), with longer treatment durations yielding more noticeable benefits, according to a thorough meta-analysis published in 2025 that synthesised 25 studies involving 1,878 patients with type 2 diabetes
The injection : administered into your deltoid (upper arm) or, occasionally, the upper outer hip, by a licensed nurse practitioner or trained medical assistant under nurse-practitioner supervision